Atlas Trials

Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia

Clinical trial NCT06842966 · RECRUITING

Trial details

NCT number
NCT06842966
Sponsor
Valenta Pharm JSC
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic CholecystitisBiliary Dyskinesia
Start date
2024-10-17
Primary completion
2026-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.